TY  - JOUR
T1  - The Physiological and Biochemical Evaluation of Tulathromycin Premix in Pigs
AU - Qu, Baohan AU - Hao, Zhihui AU - Zhao, Yongda AU - Wu, Haoting AU - Hao, Lihua AU - Ding, Zhaopeng AU - Yang, Fenfang 
JO  - Journal of Animal and Veterinary Advances
VL  - 11
IS  - 22
SP  - 4161
EP  - 4166
PY  - 2012
DA  - 2001/08/19
SN  - 1680-5593
DO  - javaa.2012.4161.4166
UR  - https://makhillpublications.co/view-article.php?doi=javaa.2012.4161.4166
KW  - Tulathromycin
KW  -physiological indexes
KW  -biochemical indexes
KW  -safety evaluation
KW  -oral
KW  -pig
AB  - The aim of the study was to investigated the influence of 
  dietary inclusion of tulathromycin at 5 mg kg<SUP>-1</SUP> die on haematological 
  to provide an experiment support for the clinical use of this drug. Eighteen 
  pigs were randomly allocated to three treatment groups. A further six pigs were 
  left untreated as controls (group NTXL). Tulathromycin was administered twice 
  by the oral route administrations of 5, 15, 25 mg kg<SUP>-1</SUP> B.W. in three 
  treatment groups on the 1st and the 4th day, respectively. Blood samples were 
  taken from all animals on days 1, 17, 14 for serum chemical and hematology evaluation. 
  Weight and temperature were measured from all animals at the same time. Comparisons 
  of mean physical examination parameters between treatment and control groups 
  over the 14 day study period revealed no significant differences (p&gt;0.05). 
  All pigs did not show any signs of discomfort after Premix. Hematology evaluation 
  indicated that comparisons of RBC, WBC, HGB, HCT, MCV, MCH, MCHC and PLT between 
  treatment and control groups also revealed no significant differences (p&gt;0.05). 
  AST, ALT, ALP, ALB, BUN were significantly higher in treated groups when compared 
  with the control group (p&lt;0.05) post-treatment. No significant differences 
  as time goes on suggesting that a slight effect of injury on liver was caused 
  by tulathromycin. The safety of tulathromycin Premix in target animal swine 
  indicated that pigs were administered of 5-25 mg kg<SUP>-1</SUP> B.W. via the 
  oral route satisfied clinicians&#146; 
  demands.
ER  -